OLMA - Olema Oncology to Participate in Upcoming Investor Conferences in May | Benzinga
SAN FRANCISCO, May 01, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (("Olema", "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers, today announced that its management team will participate in the following upcoming investor conferences:
BofA Securities Health Care Conference 2024
Date: Tuesday, May 14, 2024, at 4:35 p.m. PT
Location: Encore Hotel in Las Vegas, NV
Format: Presentation
H.C. Wainwright 2nd Annual BioConnect Investor Conference
Date: Monday, May 20, 2024, ...